Canaccord Genuity analyst John Newman maintained a Buy rating on Kaleido Biosciences (KLDO) yesterday and set a price target of $19.00.
The post Kaleido Biosciences (KLDO) Gets a Buy Rating from Canaccord Genuity appeared first on Smarter Analyst.
Canaccord Genuity analyst John Newman maintained a ...

https://www.smarteranalyst.com/new-blurbs/kaleido-biosciences-kldo-gets-a-buy-rating-from-canaccord-genuity/

#SmarterAnalyst